The high stakes of pricing a coronavirus drug
Now that the federal government is allowing the emergency use of remdesivir for coronavirus patients, and as the world awaits final clinical data on the drug’s effectiveness, a giant question looms: What will the price be?
Why it matters: Gilead’s pricing decision is important on its own, but it also will set the bar for how all coronavirus treatments that come after remdesivir will be priced, Axios’ Bob Herman reports.
